Provided by Tiger Fintech (Singapore) Pte. Ltd.

Molecular Templates, Inc.

0.0000
-0.0004-99.75%
Volume:3.00K
Turnover:0.02
Market Cap:6.58
PE:NAN
High:0.0000
Open:0.0000
Low:0.0000
Close:0.0004
Loading ...

Company Profile

Company Name:
Molecular Templates, Inc.
Exchange:
EXPERT
Establishment Date:
2001
Employees:
62
Office Location:
9301 Amberglen Boulevard,Suite 100,Austin,Texas,United States
Zip Code:
78729
Fax:
- -
Introduction:
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.